Prominent scientists are warning that Silicon Valley’s near-term predictions of AI cures for cancer, Alzheimer’s disease and other illnesses are moving ahead of clinical evidence. The skepticism is aimed less at AI-assisted biology than at treating early computational results as if they were proven medicine.A recent report on the debate describes pushback from researchers including cardiologist Eric Topol, who argued that expecting new drugs to transform several common diseases within five or 10 years has no historical precedent.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.